Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Human Growth Hormone (HGH) Market Outlook, 2022: Prevalence of Pituitary Dysfunction / Low Market Penetration / Growing Geriatric Population / Rising Healthcare Expenditure and Affordability - Research and Markets


News provided by

Research and Markets

08 Mar, 2017, 13:15 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, Mar 08, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Human Growth Hormone (HGH) - Market Outlook 2022" report to their offering.

Owing to growth stimulating properties of HGH, excessive secretion leads to acromegalic gigantism; while deficiency of GH leads to Growth Hormone Deficiency (GHD), which is a chronic disease affecting both children and adults. GHD in children is characterized by reduced growth performance and a loss of height in comparison to peers. GHD during adulthood manifests symptoms like weight gain, reduced energy levels, disturbed sleep, etc. Standard therapies for treatment of GHD includes administration of recombinant human growth hormone through injections, releasers, sprays, etc.

Growth of the global Human Growth Hormone market is driven by increase in prevalence of pituitary dysfunction, growing geriatric population, high market opportunity due to lower rHGH market penetration across nations, rising healthcare expenditure and affordability. Major factors restraining growth of the market are high treatment cost of rHGH, adverse side-effects of synthetic HGH, illicit use of HGH, poor adherence to therapy by patients and stringent regulatory approvals involved.

In the report, human growth hormone market assessment is done across major markets such as Europe, The US and Japan. The US is the world's largest HGH market accounting for more than one-third of global HGH market value. In-depth analysis of HGH therapy in aforementioned regions is done on the basis of overall HGH market value as well as pediatric HGH market.

Global human growth hormone therapy industry is highly consolidated with three major players - Novo Nordisk, Pfizer and Eli Lilly and Company dominating the market. These industry players as well as other leading players such as Merck KGaA and Roche are profiled herein based on attributes such as business overview, product segments, financial and business strategies. The report also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global HGH therapy market.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Human Growth Hormone
    3.1 Overview
    3.2 The Pathophysiology of Growth Hormone
        3.2.1 Molecular Basis of GH Action
        3.2.2 Metabolic Effects of GH
    3.3 Growth Hormone Deficiency
        3.3.1 Pediatric GHD
        3.3.2 Adult GHD
        3.3.3 Other Diorders
    3.4 Recombinant HGH
        3.4.1 Inclusion Body Technology
        3.4.2 Protein Secretion Technology
        3.4.3 Mouse-Cell Technology

4. Human Growth Hormone Market Analysis
    4.1 Market Sizing
        4.1.1 Market Size by Value (Actual & Forecasted)
        4.1.2 Market Size by Volume (Actual & Forecasted)
        4.1.3 Market Share by Region
    4.2 HGH Market by Segment
        4.2.1 Market Share
        4.2.2 Pediatric GHD market
        4.2.3 Adult GHD market

5. GH Deficiency Therapy
    5.1 Diagnosis
    5.2 Therapy for Various GHDs
    5.3 Treatment Options
        5.3.1 HGH Injections
        5.3.2 HGH Releasers
        5.3.3 Homeopathic HGH
        5.3.4 Others
    5.4 Human Growth Hormone (HGH) Replacement
        5.4.1 Overview
        5.4.2 Benefits of HGH Replacement

6. Global HGH Market Regional/Country Analysis
    6.1 Europe
        6.1.1 Overview
        6.1.2 rhGH Market Sizing (Actual & Forecasted)
        6.1.1 Pediatric rhGH Market Sizing (Actual & Forecasted)
    6.2 The US
        6.2.1 Overview
        6.2.2 rhGH Market Sizing (Actual & Forecasted)
        6.2.1 Pediatric rhGH Market Sizing (Actual & Forecasted)
    6.3 Japan
        6.3.1 Overview
        6.3.2 rhGH Market Sizing (Actual & Forecasted)
        6.3.1 Pediatric rhGH Market Sizing (Actual & Forecasted)

7. Global HGH Market Dynamics
    7.1 Industry Trends & Developments
        7.1.1 Advent of Long-acting rhGH
        7.1.2 Use of HGH as Performance Enhancers
        7.1.3 Products Under Development
    7.2 Growth Drivers
        7.2.1 Prevalence of Pituitary Dysfunction
        7.2.2 Low Market Penetration
        7.2.3 Growing Geriatric Population
        7.2.4 Rising Healthcare Expenditure and Affordability
    7.3 Challenges
        7.3.1 High Treatment Cost
        7.3.2 Adverse Side-effects of rhGH
        7.3.3 Illicit Uses of HGH
        7.3.4 Reimbursement Issues for Patients
        7.3.5 Poor Adherence to Therapy by Patient
        7.3.6 Stringent Regulatory Approvals

8. Competitive Landscape
    8.1 Brand Analysis
    8.2 Drugs by Disorders
    8.3 Market Share by Competitors

9. Company Profiles
    9.1 Merck Serono
    9.2 Novo Nordisk
    9.3 Pfizer
    9.4 Eli Lilly
    9.5 F. Hoffmann-La Roche Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/dlvnlt/global_human

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.